Chard Daniel R sold $226K of MED (indirect holdings)
Chard Daniel R sold 19,089 indirectly-held shares of MEDIFAST INC (MED) at an average of $11.85 ($11.73–$11.98, $0.23M total) across 2 trades over 2026-09-28 to 2026-09-29 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is a primary source but modest in size, likely resulting in limited price movement.
Market read
A small insider sell by a director may cause slight bearish sentiment but is unlikely to move the stock materially.
What to watch
Potential upcoming corporate actions or earnings that may have prompted the director to lock in cash.
Background
Form 4 filings disclose insider transactions; this filing reports a director's sale under a 10b5‑1 plan.
Ticker impact
Director Chard Daniel R sold 19,091 shares for $226,288, reducing his holdings to 130,609 shares.
likely modest downside as investors price in the director's sell-off
A $226K sale by a director is a primary disclosure but the amount is small; market reaction is typically limited but can nudge the stock lower.
Market effects
Minimal impact on the health and nutrition sector; the sale is company‑specific.
No broader regional effect.
Limited to MED investors.
Counterpoint
The sale could be routine portfolio rebalancing unrelated to company fundamentals.
Key entities
- CompanyMedifast Inc.
US‑listed health and nutrition company (ticker MED).
- IndividualChard Daniel R
Director of Medifast who executed the sale.
